- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
24
Stocks where the price continues to rise after more than a year of consistent gains.
24 companies
Arrowhead Pharmaceuticals
Market Cap: US$10.5b
Develops medicines for the treatment of intractable diseases in the United States.
ARWR
US$88.70
7D
23.5%
1Y
457.2%
AtaiBeckley
Market Cap: US$2.6b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.
ATAI
US$7.18
7D
34.0%
1Y
85.1%
Harbin Pharmaceutical Group
Market Cap: CN¥15.1b
Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
600664
CN¥5.98
7D
33.2%
1Y
50.6%
CareDx
Market Cap: US$2.0b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$37.78
7D
27.0%
1Y
188.0%
Xencor
Market Cap: US$1.5b
A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.
XNCR
US$19.51
7D
30.2%
1Y
103.9%
Forte Biosciences
Market Cap: US$1.2b
Operates as a clinical-stage biopharmaceutical company in the United States.
FBRX
US$56.63
7D
28.3%
1Y
432.2%
Gansu Longshenrongfa Pharmaceutical IndustryLTD
Market Cap: CN¥4.0b
Researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.
300534
CN¥13.26
7D
22.8%
1Y
25.1%
Cybin
Market Cap: US$502.1m
Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders.
HELP
US$7.82
7D
20.1%
1Y
0.8%
Valerio Therapeutics Société anonyme
Market Cap: €390.6m
A clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies.
ALVIO
€0.78
7D
71.3%
1Y
1,327.0%
EI- Nile for Pharmaceuticals and Chemical Industries
Market Cap: ج.م11.8b
Develops, produces, and sells pharmaceutical products in Egypt.
NIPH
ج.م236.01
7D
22.9%
1Y
276.3%
GlaxoSmithKlineE
Market Cap: ج.م10.2b
Engages in production of pharmaceutical chemicals.
BIOC
ج.م121.70
7D
38.2%
1Y
175.2%
Cue Biopharma
Market Cap: US$140.5m
A clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders.
CUE
US$34.20
7D
20.0%
1Y
28.1%
Great Novel Therapeutics Biotech & Medicals
Market Cap: NT$2.9b
Engages in the development of drugs for the treatment of advanced and refractory cancers in Taiwan.
7427
NT$68.30
7D
22.0%
1Y
86.6%
EOM Pharmaceuticals Holdings
Market Cap: US$16.5m
A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.
IMUC
US$0.25
7D
65.3%
1Y
147.9%
Numinus Wellness
Market Cap: US$16.0m
Provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States.
NUMI.F
US$0.048
7D
36.5%
1Y
77.6%
Panacea Life Sciences Holdings
Market Cap: US$7.5m
Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.
PLSH
US$0.13
7D
25.5%
1Y
287.3%
Delex Healthcare Group
Market Cap: US$5.7m
Engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.
DELX
US$0.0095
7D
63.8%
1Y
9.7%
Stem Cells Spin
Market Cap: zł21.3m
Operates as a biotechnology company in Poland.
SCS
zł0.52
7D
25.6%
1Y
47.1%
Blueberries Medical
Market Cap: CA$7.4m
A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.
BBM
CA$0.015
7D
50.0%
1Y
50.0%
BPH Global
Market Cap: AU$4.7m
Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.
BP8
AU$0.002
7D
33.3%
1Y
0%
Maple Leaf Green World
Market Cap: US$1.3m
Does not have significant operations.
MGWF.F
US$0.034
7D
121.6%
1Y
142.3%
co.don
Market Cap: €427.6k
Does not have significant operations.
CNW
€0.016
7D
28.0%
1Y
0%
Greater Cannabis Company
Market Cap: US$316.7k
Engages in the development and commercialization of cannabinoid therapeutics.
GCAN
US$0.31
7D
22.8%
1Y
3.3%
Myrexis
Market Cap: US$241.4k
Focuses on identifying, evaluating, and making financial investments in life sciences assets.
MYRX
US$0.007
7D
775.0%
1Y
3,400.0%